Cannabis stocks had a rough time over the past year, with the EFT Alternative Harvest ETF (NYSEMKT: MJ) and the AdvisorShares Pure Cannabis ETF (NYSEMKT: YOLO) down by more than 53% and 64%, respectively.
A glut of cannabis and falling revenues were the most obvious reasons for the share price declines of many cannabis companies. Investors also soured a bit on the sector when Congress again failed to advance federal decriminalization or pass the SAFE Banking Act.
However, despite the gloomy environment, a handful of cannabis companies reported double-digit percentage revenue gains in the third quarter, either sequentially, year over year, or both. Three that stand out among them are Ascend Wellness (OTC: AAWH) , Jazz Pharmaceutical (NASDAQ: JAZZ) , and Green Thumb Industries (OTC: GTBIF) .
For further details see:
3 Cannabis Stocks With Double-Digit Percentage Revenue Growth